key: cord-1003425-nvnywwcn authors: Falcone, Valeria; Ridder, Gerd J.; Panning, Marcus; Bierbaum, Sibylle; Neumann-Haefelin, Dieter; Huzly, Daniela title: Human Bocavirus DNA in Paranasal Sinus Mucosa date: 2011-08-03 journal: Emerg Infect Dis DOI: 10.3201/eid1708.101944 sha: 038f7612653a0732ece011b4cc49e29d305d345b doc_id: 1003425 cord_uid: nvnywwcn nan To the Editor: Human bocavirus (HBoV) is a newly described parvovirus for which pathogenic potential has not clearly been elucidated (1) . Recent fi ndings suggest that HBoV may establish persistent infection of mucosal lymphocytes or contribute to tonsillar hyperplasia in children (2) . In previous reports, we described prolonged HBoV DNA detection in immunocompromised children (3, 4) . Partial sequencing of the VP1 gene of HBoV from bronchoalveolar lavage fl uid, plasma, and sphenoid sinus samples showed 100% identity, which suggested persistence of the same HBoV strain over a 5-month period (3) . It remains speculative, however, whether paranasal sinus mucosa represents a site of HBoV persistence. To clarify this, we analyzed samples of paranasal mucosal tissue and nasal polyps from patients with chronic sinusitis for respiratory viruses and atypical bacteria. A total of 102 tissue samples were obtained from 88 patients (median age 48.5 years, range 13.3-88.1 years) from July 2009 through September 2010 after elective surgery. Indication for surgery was established by otorhinolaryngologists. The most common indication was chronic sinusitis. No patients displayed acute respiratory symptoms at the time of surgery. To detect asymptomatic shedding in the upper respiratory tract and viremia, we collected nasal swabs and EDTA-blood samples concurrently. The study protocol was approved by the Ethics Committee of the University of Freiburg. Informed written consent was obtained from all study participants. Approximately 25 mg of each tissue specimen was used for nucleic acid extraction by using an RNeasy Mini Kit, as described (5) No correlation between C t value and patients' age was observed (r 2 = 0.008; data not shown). No underlying disease was diagnosed for 13/18 HBoV-positive patients, whereas 2/18 and 3/18 patients had chronic obstructive pulmonary and oncologic disease, respectively. Nasal swabs and EDTA-blood samples were obtained from 17/18 and 7/18 HBoV-positive patients, respectively. No HBoV was detected in any swabs or EDTA-blood samples available, indicating no virus shedding in the respiratory tract and no viremia. However, the 2 patients with rhinovirus-positive samples obtained from biopsy also had rhinovirus RNA detectable in nasal swabs, suggesting rhinovirus infection. Unfortunately, no nasal swab was available from the 2 patients whose sinus biopsy samples LETTERS were positive for HCoV 229E and infl uenza A virus. In this study, we simultaneously analyzed tissue specimens of paranasal sinuses and nasal polyps, as well as nasal swabs and blood samples, for a broad panel of viruses and atypical bacteria. To avoid seasonal bias, specimens were collected over a 1-year period and exclusively obtained from patients undergoing elective surgery in the absence of acute respiratory symptoms. The fi nding that HBoV was present as a single virus in 18/22 viruspositive biopsy samples is intriguing. Moreover, the fact that no HBoV DNA was detected in nasal swabs or EDTAblood samples indicates no active HBoV infection. In previous studies, HBoV DNA was frequently identifi ed in the adenoids and tonsils of children (2, 5, 10) . However, in contrast with our fi ndings, detection of HBoV was mostly associated with other viruses, suggesting that co-virus-induced cellular damage might contribute to bocavirus reactivation and replication (5) . Our fi ndings indicate that persistence of viral nucleic acid in sinus mucosa might be a special advantage of HBoV, although the relevance of this observation remains unclear. Whether this presence as a single virus means a dead end for HBoV infection, true latency including the potential of reactivation, or a role in the pathogenesis of clinical conditions requiring surgery warrants future studies. The human bocaviruses: a review and discussion of their role in infection Human bocavirus in tonsillar lymphocytes Persistence of human bocavirus DNA in immunocompromised children Disseminated bocavirus infection after stem cell transplant Frequent detection of respiratory viruses by real-time PCR in adenoid samples from asymptomatic children Development of a multiplex real-time quantitative PCR assay to detect Chlamydia pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae in respiratory tract secretions Identifi cation and evaluation of new target sequences for specifi c detection of Bordetella pertussis by real-time PCR Sensitive detection of Mycoplasma pneumoniae in human respiratory tract samples by optimized real-time PCR approach Realtime PCR for diagnosis of human bocavirus infections and phylogenetic analysis Detection of viruses in human adenoid tissues by use of multiplex PCR We are grateful to Gudrun Woywodt for excellent technical assistance. To the Editor: The prevalence of hepatitis C virus (HCV) infection is high (8% of the population) in Pakistan (1). HCV is an RNA virus that has a high mutation rate. This high rate results in extensive genetic heterogeneity, and HCV isolates are found as either quasispecies or genotypes (2) . Humans can be co-infected with >1 genotype (mixed genotype infection) of this virus (3) . The rate of HCV mixed genotype infections is extremely variable for different regions and for the same group of patients tested by using different assays (4). Thus, it is diffi cult to determine the prevalence of mixed genotype infections by currently available assays, including direct DNA sequencing, because they are designed to identify only the HCV genotype dominant in that particular population. Consequently, genotypes present at lower frequencies could be missed or mistyped (5) .To determine the prevalence of HCV mixed genotype infections, we retrospectively analyzed genotyping data for paired serum samples from 22,125 HCV-infected patients during the past 11 years (March 2000-May 2010) for all regions in Pakistan by using molecular-based genotypespecifi c methods (6, 7) . A total of 12,036 (54.4%) were male patients and 10,089 (45.6%) were female patients.